JPRN-UMIN000002653Recruiting未知
A study on the effects of eicosapentaenoic acid (EPA) on arteriosclerosis in hemodialysis patients with percutaneous coronary intervention (PCI) - A study on the effects of eicosapentaenoic acid (EPA) on arteriosclerosis in hemodialysis patients with percutaneous coronary intervention (PCI)
agoya Kyoritsu Hospital0 sites100 target enrollmentStarted: November 1, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) A history of hypersensitivity to highly purified EPA preparations. 2) Have had the onset of stroke within the past 6 months. 3) Left ventricular ejection fraction below 40%. 4) Are currently pregnant or may be pregnant. 5) Suffering from hemorrhage (e.g., hemophilia, capillary fragility, gastrointestinal hemorrhage, urinary tract hemorrhage, hemoptysis and vitreous hemorrhage). 6) A peptic ulcer. 7) Extremely poor bile secretion or severe hepatic dysfunction. 8) Others judged to be inappropriate to participate in the current study.
Investigators
Similar Trials
Completed
Not Applicable
Evaluation of the effect of eicosapentaenoic acid on plaques in human carotid arteriesAtherosclerotic plaques in carotid arteries.JPRN-UMIN000004114Institute of Health Biosciences, the University of Tokushima Graduate School, Department of Cardiovascular Medicine10
Completed
Not Applicable
Evaluation of the impact of eicosapentaenoic acid on postprandial hyperglycemia, hyperliopemia and endothelial dysfunction in mild diabetic and impaired glucose tolerance patients with coronary artery disease.untreated mild diabetic patients (HbA1c<7.0%) and impaired glucose tolearenceJPRN-UMIN000011265Hyogo Brain and Heart Center80
Completed
Phase 3
Eicosapentaenoic acid in the treatment of pediatric atopic dermatitisIRCT20170608034390N2Shahid Beheshti University of Medical Sciences40
Completed
Not Applicable
Comparison of the effect of eicosapentaenoic acid and docosahexaenoic acid on the treatment of depressioRecurrent depressive disorder.Recurrent depressive disorderIRCT201010054873N1Research Accessory of Shahid Sadughi University of Medical Sciences81
Completed
Not Applicable
Study of the Effects of eicosapentaenoic acid on diabetic atherosclerotic lesioType 2 diabetesJPRN-UMIN000007835Osaka University Graduate School44